RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Accounts receivable, net

Edwards Lifesciences CorpEW

Market cap
$50.9B
P/E ratio
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Dec 31, 2024609-21.42%
Dec 31, 2023775+20.54%
Dec 31, 2022643+10.44%
Dec 31, 2021582+13.14%
Dec 31, 2020515-5.33%
Dec 31, 2019544+18.98%
Dec 31, 2018457+8.37%
Dec 31, 2017422+15.35%
Dec 31, 2016366+15.88%
Dec 31, 2015315+9.51%
Dec 31, 2014288-4.79%
Dec 31, 2013303-5.79%
Dec 31, 2012321+13.14%
Dec 31, 2011284+2.34%
Dec 31, 2010277

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)